Please login to the form below

How to measure marketing success: profit vs ROI

Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and effectiveness, along with the formula for calculating profit and ROI.
Return on investment (ROI) and measuring financial payback is one of my favourite topics and one that has been identified as a major hurdle for pharma marketers, behind legal and regulatory issues. Although many marketers know that proving ROI is a great way to secure budget through proof of your marketing prowess, understanding what to measure to show both efficiency and effectiveness can seem daunting. Here, I will explore marketing effectiveness in detail, revealing practical tools and tips for demonstrating the success of your campaigns.

The true definition of marketing effectiveness

I hear the letters ‘R.O.I.’ thrown around a lot these days and in one way that’s a good thing. However, despite all this talk, I’m a little bewildered as to what is being classed as marketing success. 

For example, which do you think is the better campaign?

A) 200% (or 2:1) ROI
B) 250% (or 2.5:1) ROI.

Obviously, Campaign B looks more successful but what if I give you more data?

A) 200% ROI, €1,200,000 net profit
B) 250% ROI, €250,000 net profit. 

After seeing the contribution to the business, it is clear campaign A was more successful. Although it may not have been as efficient as Campaign B, it was more effective. Campaign A contributed more profit to the business, which will have a greater impact on the company’s share price.

Although profit is often the ultimate motive for companies, research commissioned by the Institute of Practitioners in Advertising (IPA) suggests less than 20% of marketing activity is evaluated in terms of financial payback. While it is nice to hear marketers talk about ROI and put in place the processes to measure it, we are ultimately here to deliver profit. If you are too fixated on delivering ROI, or return on marketing investment (ROMI) as it should technically be referred to in marketing, you will only end up creating campaigns that use efficient channels and tactics rather than delivering the most profit.

What makes us successful?

Sarah McDonald, Global Digital Communications Manager at Pfizer, explains that ROI only provides a short-term view of success. She says: “Our metrics are based on product ROI and we see that as very short-term. What we really should be measuring are those long-term account-based metrics – building relationships, looking at the services beyond the pill that we can provide at Pfizer, looking at having those joint plans that are built with our key accounts – rather than just looking at the dollar sign at the end of it.” 

In a way, I can’t help but agree with Sarah. Not everyone in life measures their success from the money they earn. For many people, success is family, friends, love, happiness, and fulfillment. So, while it is important to make a profit, delivering a return for investors is not always the be-all and end-all. ROMI and profit may simply act as metrics, while measures for success are more aligned with your company or brand vision.

Although Bill Gates is worth $86.4bn, he defines his success as making the personal computer commonplace in the home rather than the billions of dollars he earned in doing so, seeing money is just a by-product of his achievements. When asked about his idea of success, he said: “The chance to be part of the software revolution empowering people was the biggest thing I have gotten to do.”

How to measure effectiveness

1. Measuring the sales effect 
The first step in measuring effectiveness is often the most difficult – calculating the sales effect. This is the incremental sales revenue generated by the marketing activity and can be measured in three ways. An econometrician can help here by doing some econometric modeling.

A popular approach is the test and control method. This involves comparing the uplift in sales from an area or market exposed to the marketing activity and a similar area or market that wasn’t. Alternatively, you can extrapolate from a trend but you would need a relatively consistent trend to be showing (i.e. practically 0% revenue growth for the 6 months prior) to use this method.



Download the full article from Blue Latitude Health

12th January 2018

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Three strategies for managing loss of exclusivity successfully
Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
What does the future hold for Medical Affairs?
Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
Unpacking rare diseases in the first edition of Delta magazine
Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health